| |
| |
|
| Insider
Information: |
Flynn Karen |
| Relationship: |
|
| City: |
Lionville |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
113,719 |
|
|
Indirect Shares
|
1,550 |
|
|
| Direct
Value |
$9,668,734 |
|
|
|
Indirect Value
|
$514,073 |
|
|
| Total
Shares |
115,269 |
|
|
| Total
Value |
$10,182,807 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
West Pharmaceutical Services Inc |
WST |
|
2019-02-19 |
23,692 |
2017-12-01 |
1,550 |
Premium* |
|
|
Societal CDMO, Inc |
SCTL |
Director |
2019-12-05 |
39,283 |
2016-12-16 |
0 |
Premium* |
|
|
Catalent, Inc. |
CTLT |
Director |
2023-10-27 |
24,339 |
2020-01-08 |
0 |
Premium* |
|
|
Quanterix Corp |
QTRX |
|
2024-01-02 |
26,405 |
2022-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
87 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CTLT |
Catalent, Inc. |
Pres. Biologics & CCO |
• – – |
2021-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,151 |
35,695 |
0 |
- |
|
| CTLT |
Catalent, Inc. |
Chief Commercial Officer |
• – – |
2022-01-10 |
4 |
AS |
$116.64 |
$288,334 |
D/D |
(2,472) |
33,223 |
0 |
% |
|
| QTRX |
Quanterix Corp |
|
– • – |
2022-07-01 |
4 |
A |
$16.79 |
$2,754 |
D/D |
164 |
13,391 |
0 |
- |
|
| CTLT |
Catalent, Inc. |
Director |
– • – |
2022-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
245 |
13,197 |
0 |
- |
|
| QTRX |
Quanterix Corp |
|
– • – |
2022-10-03 |
4 |
A |
$10.48 |
$11,172 |
D/D |
1,066 |
14,457 |
0 |
- |
|
| CTLT |
Catalent, Inc. |
Director |
– • – |
2022-10-27 |
4 |
A |
$0.00 |
$0 |
D/D |
4,149 |
17,346 |
0 |
- |
|
| QTRX |
Quanterix Corp |
|
– • – |
2023-01-03 |
4 |
A |
$0.00 |
$11,805 |
D/D |
9,001 |
23,458 |
0 |
- |
|
| CTLT |
Catalent, Inc. |
Director |
– • – |
2023-10-27 |
4 |
A |
$0.00 |
$0 |
D/D |
6,993 |
24,339 |
0 |
- |
|
| QTRX |
Quanterix Corp |
|
– • – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,947 |
26,405 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
President, Americas RegionOffi |
• – – |
2012-07-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,474 |
|
- |
|
| CTLT |
Catalent, Inc. |
Director |
– • – |
2022-09-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,952 |
|
% |
|
| WST |
West Pharmaceutical Servi... |
President, Americas RegionOffi |
• – – |
2012-07-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
155 |
|
- |
|
87 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
